TY - JOUR T1 - Impact of mental disorders on active tuberculosis treatment outcomes: a systematic review and meta-analysis JF - medRxiv DO - 10.1101/2020.06.19.20135913 SP - 2020.06.19.20135913 AU - Ga Eun Lee AU - James Scuffell AU - Jerome T. Galea AU - Sanghyuk S. Shin AU - Elizabeth Magill AU - Ernesto Jaramillo AU - Annika C. Sweetland Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/11/06/2020.06.19.20135913.abstract N2 - Background Comorbid mental disorders in patients with tuberculosis (TB) may exacerbate TB treatment outcomes. We systematically reviewed current evidence on the association between mental disorders and TB outcomes.Methods We searched eight databases for studies published from 1990-2018 that compared TB treatment outcomes among patients with and without mental disorders. We excluded studies that did not systematically assess mental disorders and studies limited to substance use. We extracted study and patient characteristics and effect measures and performed a meta-analysis using random-effects models to calculate summary odds ratios (OR) with 95% confidence intervals (CI).Findings Of 7,687 studies identified, ten were included in the systematic review and nine in the meta-analysis. Measurement of mental disorders and TB outcomes were heterogeneous across studies. The pooled association between mental disorders and any poor outcome, loss to follow-up, and non-adherence were OR 2.13 (95% CI: 0.85-5.37), 1.90 (0.33-10.91), and 1.60 (0.81-3.02), respectively. High statistical heterogeneity was present.Interpretation Our review suggests that mental disorders in TB patients increase the risk of poor TB outcomes, but pooled estimates were imprecise due to small number of eligible studies. Integration of psychological and TB services might improve TB outcomes and progress towards TB elimination.Competing Interest StatementDr. Sweetland is a compensated Board Member of Chemonics International, Inc. Dr. Shin has received consulting fees from Beckman Coulter, Inc and Hycor Biomedical.Clinical Protocols https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=122382 Funding StatementFunding was provided in part by the US National Institute of Mental Health (NIMH grant K01 MH104514) and National Institute of Allergy and Infectious Diseases (NIAID grant K01 AI118559).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This work did not require ethical approcal.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData used in the manuscript is available on request to the authors. ER -